文献速递主动脉外科

胸主动脉腔内修复术后心脏重构研究

Cardiac remodelling following thoracic endovascular aortic repair for descending aortic aneurysms.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

本研究基于密歇根大学数据库,纳入8例接受胸主动脉腔内修复术(TEVAR)的降主动脉疾病患者,通过影像学工作流评估左心室每搏功与质量变化。结果显示TEVAR后左心室每搏功增加26%,超声和CT测量的左心室质量指数分别增加26%和15%,且质量指数变化与每搏功及平均血压变化正相关。结论提示TEVAR与左心室做功和质量增加相关,建议开发更顺应性的器械并加强术后降压管理。

要点

  • TEVAR后左心室每搏功增加26%,左心室质量指数增加15%-26%。
  • 左心室质量指数变化与每搏功和平均血压变化正相关。
  • 建议研发更顺应性器械并加强TEVAR术后降压管理。

核心结论

  • TEVAR与随访期间左心室每搏功和质量增加相关。
  • 器械制造商应开发更顺应性器械以减少与主动脉的硬度不匹配。
  • TEVAR术后需要强化降压管理以控制血压。

研究设计与样本

  • 回顾性研究,搜索密歇根大学数据库2013-2016年因降主动脉病变接受TEVAR的患者。
  • 纳入有TEVAR前后CT血管造影和超声心动图数据的患者,共8例。
  • 通过患者特异性流固耦合分析估算左心室每搏功,通过超声和心电门控CT血管造影形态学测量量化左心室重构。

主要发现

  • 流固耦合模拟计算TEVAR后左心室每搏功增加26%[0.94(0.89,0.34)J至1.18(1.11,0.65)J,P=0.012]。
  • 超声测量左心室质量指数术后增加26%[72(73,17)g/m2至91(87,26)g/m2,P=0.017]。
  • CT血管造影测量左心室质量指数术后增加15%[52(46,29)g/m2至60(57,22)g/m2,P=0.043]。
  • 术后/术前左心室质量指数比值与每搏功比值正相关(ρ=0.690,P=0.058),与平均血压比值正相关(ρ=0.786,P=0.021)。

临床怎么用

  • TEVAR术后应关注左心室做功和质量变化,加强血压管理。
  • 选择或研发更顺应性的腔内移植物可能有助于减少心脏重构。

局限性

  • 样本量小,仅8例患者。
  • 为单中心回顾性研究。
  • 随访时间和影像学数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Current endografts for thoracic endovascular aortic repair (TEVAR) are much stiffer than the aorta and have been shown to induce acute stiffening. In this study, we aimed to estimate the impact of TEVAR on left ventricular (LV) stroke work (SW) and mass using a non-invasive image-based workflow. METHODS: The University of Michigan database was searched for patients treated with TEVAR for descending aortic pathologies (2013-2016). Patients with available pre-TEVAR and post-TEVAR computed tomography angiography and echocardiography data were selected. LV SW was estimated via patient-specific fluid-structure interaction analyses. LV remodelling was quantified through morphological measurements using echocardiography and electrocardiographic-gated computed tomography angiography data. RESULTS: Eight subjects were included in this study, the mean age of the patients was 68 (73, 25) years, and 6 patients were women. All patients were prescribed antihypertensive drugs following TEVAR. The fluid-structure interaction simulations computed a 26% increase in LV SW post-TEVAR [0.94 (0.89, 0.34) J to 1.18 (1.11, 0.65) J, P = 0.012]. Morphological measurements revealed an increase in the LV mass index post-TEVAR of +26% in echocardiography [72 (73, 17) g/m2 to 91 (87, 26) g/m2, P = 0.017] and +15% in computed tomography angiography [52 (46, 29) g/m2 to 60 (57, 22) g/m2, P = 0.043]. The post- to pre-TEVAR LV mass index ratio was positively correlated with the post- to pre-TEVAR ratios of SW and the mean blood pressure (ρ = 0.690, P = 0.058 and ρ = 0.786, P = 0.021, respectively). CONCLUSIONS: TEVAR was associated with increased LV SW and mass during follow-up. Medical device manufacturers should develop more compliant devices to reduce the stiffness mismatch with the aorta. Additionally, intensive antihypertensive management is needed to control blood pressure post-TEVAR.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. van Bakel TMJ, Arthurs CJ, Nauta FJH, et al. Cardiac remodelling following thoracic endovascular aortic repair for descending aortic aneurysms. Eur J Cardiothorac Surg. 2019. PMID: 30535179. doi:10.1093/ejcts/ezy399

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。